|
AARP prospective study of diet and cancer
|
Z01 CP010196-03152
|
$2,416,410
|
Schatzkin, Arthur
|
DCEG (NCI)
|
|
Cancer Center Core Support Grant
|
3P30CA016086-33S1
|
$90,929
|
EARP, H
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
|
Cancer Center Core Support Grant
|
3P30CA016086-33S2
|
$249,275
|
EARP, H
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
|
Cancer Center Core Support Grant
|
5P30CA016086-33
|
$6,456,063
|
EARP, H
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
|
Cancer Center Support Grant
|
3P30CA072720-12S1
|
$111,931
|
DiPaola, Robert
|
UNIV OF MED/DENT NJ-R W JOHNSON MED SCH
|
|
Cancer Center Support Grant
|
3P30CA072720-12S2
|
$132,337
|
Dipaola, Robert
|
UNIV OF MED/DENT NJ-R W JOHNSON MED SCH
|
|
Cancer Center Support Grant
|
5P30CA072720-12
|
$3,159,662
|
DiPaola, Robert
|
UNIV OF MED/DENT NJ-R W JOHNSON MED SCH
|
|
Community Clinical Oncology Program Research Base
|
3U10CA037422-21S1
|
$27,801
|
CURRAN, WALTER
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
Community Clinical Oncology Program Research Base
|
5U10CA037422-21
|
$1,665,362
|
CURRAN, WALTER
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
Dyskeratosis Congenita
|
Z01 CP010190-10374
|
$392,180
|
Savage, Sharon
|
DCEG (NCI)
|
|
EBV Expression in Nasopharyngeal Carcinoma
|
5R01CA032979-24
|
$291,685
|
RAAB-TRAUB, NANCY
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
|
EBV Genome Expression:Localization of Specific Functions
|
5R01CA030356-27
|
$330,440
|
HAYWARD, S
|
JOHNS HOPKINS UNIVERSITY
|
|
EORTC DATA CENTER
|
5U10CA011488-38
|
$793,241
|
Sylvester, Richard
|
EUROPEAN ORG/RES/TREATMENT/CANCER
|
|
Epstein-Barr Virus: Activation of WNT
|
5R01CA103634-05
|
$307,976
|
RAAB-TRAUB, NANCY
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
|
Families at high risk of cancer
|
Z01 CP004410-08285
|
$300,416
|
Tucker, Margaret
|
DCEG (NCI)
|
|
FUNCTION OF EBV EBNA-3C IN B CELL IMMORTALIZATION
|
5R01CA056645-16
|
$230,935
|
Sample, Clare
|
PENNSYLVANIA STATE UNIV HERSHEY MED CTR
|
|
Functions of EBNA1 in replication & partitioning of EBV
|
5R01CA112564-05
|
$220,812
|
Aiyar, Ashok
|
LOUISIANA STATE UNIV HSC NEW ORLEANS
|
|
GROWTH CONTROL OF NORMAL AND MALIGNANT KERATINOCYTES
|
3R01CA041556-21S1
|
$177,091
|
Reiss, Michael
|
UNIV OF MED/DENT NJ-R W JOHNSON MED SCH
|
|
GROWTH CONTROL OF NORMAL AND MALIGNANT KERATINOCYTES
|
5R01CA041556-21
|
$331,745
|
REISS, MICHAEL
|
UNIV OF MED/DENT NJ-R W JOHNSON MED SCH
|
|
LABORATORY ASSESSMENT OF TOBACCO USE BEHAVIOR AND EXPOSURE TO TOXINS AMONG USERS
|
N01PC644002-004
|
$3,600,000
|
SHIELDS, PETER
|
GEORGETOWN UNIVERSITY
|
|
MAIN LINE HEALTH CCOP
|
5U10CA063847-15
|
$477,455
|
GILMAN, PAUL
|
LANKENAU INSTITUTE FOR MEDICAL RESEARCH
|
|
Montana Cancer Consortium
|
2U10CA067575-14
|
$614,384
|
MARCHELLO, BENJAMIN
|
MONTANA CANCER CONSORTIUM
|
|
Mortality among formaldehyde workers
|
Z01 CP010120-02100
|
$30,144
|
Hayes, Richard
|
DCEG (NCI)
|
|
MOUNT SINAI COMMUNITY CLINICAL ONCOLOGY PROGRAM
|
5U10CA045564-22
|
$652,654
|
Lilenbaum, Rogerio
|
MOUNT SINAI MEDICAL CENTER (MIAMI BEACH)
|
|
Nasopharyngeal carcinoma in Taiwan
|
Z01 CP010158-01110
|
$13,099
|
Brinton, Louise
|
DCEG (NCI)
|
|
Northwest Community Clinical Oncology Program
|
2U10CA035281-25
|
$691,655
|
COLMAN, LAUREN
|
TACOMA GENERAL HOSPITAL
|
|
NPC Clinical Follow-up Study (BtoB Study)
|
Z01 CP010158-10360
|
$12,486
|
Brinton, Louise
|
DCEG (NCI)
|
|
NPC family study in Taiwan
|
Z01 CP010158-01120
|
$197,758
|
Brinton, Louise
|
DCEG (NCI)
|
|
Quality Assurance Review Center
|
5U10CA029511-29
|
$1,826,277
|
FITZGERALD, THOMAS
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
|
RADIATION THERAPY ONCOLOGY GROUP
|
3U10CA021661-32S2
|
$9,611,397
|
CURRAN, WALTER
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
RADIATION THERAPY ONCOLOGY GROUP
|
3U10CA021661-32S3
|
$3,952
|
CURRAN, WALTER
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
RADIATION THERAPY ONCOLOGY GROUP
|
3U10CA021661-32S4
|
$80,640
|
CURRAN, WALTER
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
Radiation Therapy Oncology Group-Statistical Center
|
3U10CA032115-26S1
|
$1,010,519
|
Sadek, Ramses
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
Radiologial Physics Center
|
5U10CA010953-40
|
$2,445,710
|
IBBOTT, GEOFFREY
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Regulation of EBV Infection in Epithelial Cells
|
5R01CA058853-15
|
$278,599
|
KENNEY, SHANNON
|
UNIVERSITY OF WISCONSIN MADISON
|
|
Regulation of replication and latency EBV EBNAs
|
4R37CA042245-23
|
$367,373
|
HAYWARD, S
|
JOHNS HOPKINS UNIVERSITY
|
|
Second cancers following retinoblastoma
|
Z01 CP010131-04140
|
$377,083
|
Ron, Elaine
|
DCEG (NCI)
|
|
ST Louis-Cape Girardeau CCOP
|
5U10CA035128-25
|
$456,567
|
Sleckman, Bethany
|
ST. JOHN'S MERCY MEDICAL CENTER
|
|
SUNY Downstate Medical Center Minority-Based Community Clinical Oncology Program
|
3U10CA114671-02S1
|
$100,000
|
Solomon, William
|
SUNY DOWNSTATE MEDICAL CENTER
|
|
Syracuse Hematology-Oncology CCOP
|
5U10CA045389-22
|
$575,881
|
KIRSHNER, JEFFREY
|
HEMATOLOGY-ONCOLOGY ASSOCIATES/CTL NY
|
|
The Brooklyn Minority-Based Community Clinical Oncology*
|
5U10CA114671-02
|
$554,189
|
Solomon, William
|
SUNY DOWNSTATE MEDICAL CENTER
|
|
TOLEDO COMMUNITY CLINICAL ONCOLOGY PROGRAM
|
5U10CA035415-25
|
$721,858
|
SCHAEFER, PAUL
|
TOLEDO COMMUNITY HOSPITAL ONCOLOGY PROG
|
|
Total Synthesis of Anticancer Angents Methyl Tortuoate A and B
|
5F32CA121716-02
|
$49,646
|
SPERRY, JEFFREY
|
UNIVERSITY OF PENNSYLVANIA
|
|
Use of Serum HPV16 DNA as a Marker for Oropharyngeal Cancer Recurrence
|
5R03CA128110-02
|
$77,000
|
STURGIS, ERICH
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-35S1
|
$59,955
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN MADISON
|
|
UW Comprehensive Cancer Center Support
|
5P30CA014520-35
|
$4,795,480
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN MADISON
|
|
Virginia Mason Community Clinical Oncology Program
|
5U10CA035192-25
|
$453,250
|
Vuky, Jacqueline
|
BENAROYA RESEARCH INST AT VIRGINIA MASON
|
|
VIRUS-HOST INTERACTIONS IN CANCER
|
5T32CA009031-32
|
$306,523
|
KIEFF, ELLIOTT
|
HARVARD UNIVERSITY (MEDICAL SCHOOL)
|
|
Workshops on Viral Pathogenesis and Oncogenesis
|
5R13CA095919-07
|
$9,000
|
FAN, HUNG
|
UNIVERSITY OF CALIFORNIA IRVINE
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|